Granzyme (gzm) A and gzmB have been implicated in Fas-independent nucleolytic and cytolytic processes exerted by cytotoxic T (Tc) cells, but the underlying mechanism(s) remains unclear. In this study, we compare the potential of Tc and natural killer (NK) cells of mice deficient in both gzmA and B (gzmA×B−/−) with those from single knockout mice deficient in gzmA (−/−), gzmB (−/−), or perforin (−/−) to induce nuclear damage and lysis in target cells. With the exception of perforin−/−, all in vitro– and ex vivo–derived Tc and NK cell populations from the mutant strains induced 51Cr-release in target cells at levels and with kinetics similar to those of normal mice. This contrasts with their capacity to induce apoptotic nuclear damage in target cells. In gzmA×B−/− mice, Tc/NK-mediated target cell DNA fragmentation was not observed, even after extended incubation periods (10 h), but was normal in gzmA-deficient and only impaired in gzmB-deficient mice in short-term (2–4 h), but not long-term (4–10 h), nucleolytic assays. This suggests that gzmA and B are critical for Tc/NK granule– mediated nucleolysis, with gzmB being the main contributor, while target cell lysis is due solely to perforin and independent of both proteases.
Skip Nav Destination
Article navigation
17 November 1997
Article Contents
Brief Definitive Report|
November 17 1997
In Vitro– and Ex Vivo–derived Cytolytic Leukocytes from Granzyme A × B Double Knockout Mice Are Defective in Granule-mediated Apoptosis but not Lysis of Target Cells
Markus M. Simon,
Markus M. Simon
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Michael Hausmann,
Michael Hausmann
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Thao Tran,
Thao Tran
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Klaus Ebnet,
Klaus Ebnet
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Jürg Tschopp,
Jürg Tschopp
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Ron ThaHla,
Ron ThaHla
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Arno Müllbacher
Arno Müllbacher
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Markus M. Simon
,
Michael Hausmann
,
Thao Tran
,
Klaus Ebnet
,
Jürg Tschopp
,
Ron ThaHla
,
Arno Müllbacher
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Address correspondence to Dr. Markus M. Simon, Max-Planck-Institut für Immunbiologie, Stübeweg 51, D-79108 Freiburg, Germany. Phone: 49-761-5108-533; FAX: 49-761-5108-529; E-mail: [email protected] Klaus Ebnet's present address is Institut für Zellbiologie, ZMBE, D-48149 Münster, Germany.
Received:
August 13 1997
Revision Received:
September 22 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 186 (10): 1781–1786.
Article history
Received:
August 13 1997
Revision Received:
September 22 1997
Citation
Markus M. Simon, Michael Hausmann, Thao Tran, Klaus Ebnet, Jürg Tschopp, Ron ThaHla, Arno Müllbacher; In Vitro– and Ex Vivo–derived Cytolytic Leukocytes from Granzyme A × B Double Knockout Mice Are Defective in Granule-mediated Apoptosis but not Lysis of Target Cells . J Exp Med 17 November 1997; 186 (10): 1781–1786. doi: https://doi.org/10.1084/jem.186.10.1781
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement